BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17418691)

  • 1. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the genetics of diabetic nephropathy through the study of mice.
    Breyer MD; Qi Z; Tchekneva EE; Harris RC
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):82-6. PubMed ID: 18090675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining diabetic nephropathy through the lens of mouse genetics.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Harris RC
    Curr Diab Rep; 2007 Dec; 7(6):459-66. PubMed ID: 18255011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: leveraging mouse genetics.
    Breyer MD; Qi Z; Tchekneva E
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):227-32. PubMed ID: 16609287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing genetic susceptibility to diabetic nephropathy.
    Tanaka N; Babazono T
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine models of diabetic nephropathy.
    Peters V; Schmitt CP
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):191-3. PubMed ID: 22402945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of diabetic nephropathy.
    Maeda S
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):363-71. PubMed ID: 19124434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors in the pathogenesis of diabetic nephropathy.
    Sanchez AP; Sharma K
    Expert Rev Mol Med; 2009 Apr; 11():e13. PubMed ID: 19397838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H; Grahovac G; Zeisberg M; Kalluri R
    Diabetes; 2007 Jul; 56(7):1825-33. PubMed ID: 17456853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy: a frontier for personalized medicine.
    Susztak K; Böttinger EP
    J Am Soc Nephrol; 2006 Feb; 17(2):361-7. PubMed ID: 16407421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice.
    Suzuki H; Kato I; Usui I; Takasaki I; Tabuchi Y; Oya T; Tsuneyama K; Kawaguchi H; Hiraga K; Takasawa S; Okamoto H; Tobe K; Sasahara M
    Biochem Biophys Res Commun; 2009 Jan; 379(1):38-42. PubMed ID: 19070598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy].
    Benito-Martín A; Ucero AC; Santamaría B; Lorz C; Kretzler M; Rastaldi MP; Sánchez-Niño MD; Sanz A; Izquierdo MC; Ruiz Ortega M; Egido J; Ortiz A
    Nefrologia; 2009; 29(1):13-9. PubMed ID: 19240767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases?
    Conway BR; Maxwell AP
    Nephron Clin Pract; 2009; 112(4):c213-21. PubMed ID: 19546580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.